Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has updated the name of the institution to 'Charite Universitätsmedizin Berlin KöR' and removed previous dates, indicating a shift in focus to more current information.SummaryDifference0.7%
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed eligibility criteria for a study on spesolimab treatment for generalized pustular psoriasis, while a new revision number has been added.SummaryDifference26%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 10, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference0.4%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check45 days agoChange DetectedDifference0.1%
Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.